活性栄養補助食品成分市場：タイプ、形態、健康効果、用途、流通チャネル別-2025-2030年世界予測

活性栄養補助食品成分市場は、2023年に2,273億4,000万米ドルと評価され、2024年には2,454億1,000万米ドルに達すると予測され、CAGR 8.11％で成長し、2030年には3,925億8,000万米ドルに達すると予測されています。

活性栄養補助食品成分市場には、摂取することで基本的な栄養以上の健康効果をもたらす生物活性化合物が含まれます。これらの成分には、ビタミン、ミネラル、プロバイオティクス、抗酸化物質、アミノ酸、植物抽出物などが含まれ、機能性食品、栄養補助食品、飲食品に使用されることが多いです。その必要性は、ライフスタイルの選択に関連した慢性疾患に対する意識の高まりに後押しされ、予防ヘルスケアとウェルネスに対する消費者の志向が高まっていることに起因しています。主な用途は免疫サポート、認知健康、アンチエイジング、消化器系の健康、ストレス管理に重点が置かれ、エンドユーザーは主に飲食品、医薬品、化粧品業界です。市場成長は、世界人口の高齢化、ヘルスケアコストの増加、天然・オーガニック製品に対する消費者の需要に大きな影響を受けています。さらに、持続可能性と安全基準を重視する規制状況は、製品処方の革新と持続可能な原料の調達を通じて市場拡大の機会をもたらしています。

人工知能とビッグデータ分析を活用して、個人の食事ニーズや健康状態に対応する個別化栄養ソリューションの開発にビジネスチャンスがあります。認知度と可処分所得が上昇している新興市場への進出は、成長の道をさらに開く。しかし、厳しい規制要件、研究開発・製造コストの高さ、成分のバイオアベイラビリティと安定性の複雑さといった課題が制約となっています。市場における偽造品や低品質の製品は、消費者の信頼をさらに複雑なものにしています。イノベーションは、ナノテクノロジーやカプセル化のような高度な送達システムを通じてバイオアベイラビリティを高めることに焦点を当てるべきです。代替の植物性蛋白源に関する調査と、腸内マイクロバイオームが健康に及ぼす影響の解明は、引き続き極めて重要です。市場はダイナミックでイノベーション主導の性質を示し、消費者の動向や規制の変更に継続的に適応する必要があります。企業は学術機関とのパートナーシップを活用して最先端の研究を行い、調達と生産における透明性を優先し、栄養補助食品の利点を強調するために消費者教育に取り組むべきです。食品と医薬品の境界線が曖昧になるにつれて、企業は競争力を維持するために、特定の健康問題に対処する的を絞った製品開発に注力する必要があります。

市場力学：急速に進化する活性栄養補助食品成分市場における主要市場洞察の解明

活性栄養補助食品成分市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 健康と福祉に関する意識の高まり
  • 抽出・加工技術における継続的な技術革新
• 市場抑制要因
  • 活性栄養補助食品成分の不純物混入問題に伴う製品開発の複雑さ
• 市場機会
  • 活性栄養補助食品成分を使用した新規製品の開発
  • 植物由来の栄養補助食品成分への嗜好の高まり
• 市場の課題
  • 健康強調表示を立証するための時間のかかる臨床試験と政府の厳しい承認手続き

ポーターの5つの力：活性栄養補助食品成分市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：活性栄養補助食品成分市場における外部からの影響の把握

外部マクロ環境要因は、活性栄養補助食品成分市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析活性栄養補助食品成分市場における競合情勢の把握

活性栄養補助食品成分市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス活性栄養補助食品成分市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、活性栄養補助食品成分市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 健康と幸福に関する意識の高まり
    • 抽出および処理技術における継続的な革新
  • 抑制要因
    • 製品開発の複雑さと栄養補助食品有効成分の混入問題
  • 機会
    • 栄養補助食品有効成分を使用した新製品の開発
    • 植物由来の栄養補助食品原料への人気が急増
  • 課題
    • 健康効果を実証するための時間のかかる臨床試験と厳格な政府承認手続き
• 市場セグメンテーション分析
  • タイプ：抗酸化物質が豊富なカロテノイドからプロバイオティクスまで、栄養補助食品の進歩
  • 形態：安定性と保存期間の延長により、乾燥形態の原料の使用が促進される
  • 健康上の利点：栄養と免疫力を高めるための活性栄養成分の飛躍的な使用
  • 用途：動物栄養、栄養補助食品、パーソナルケアにおける栄養補助食品の多様な用途
  • 流通チャネル：オンライン流通チャネルを通じて栄養補助食品の有効成分を幅広く入手可能
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 活性栄養補助食品成分市場：タイプ別

• カロテノイド
• 繊維と特殊炭水化物
• 鉱物
• オメガ3脂肪酸
• 植物化学物質と植物抽出物
• タンパク質とアミノ酸
• ビタミン

第7章 活性栄養補助食品成分市場：形態別

• ドライ
• 液体

第8章 活性栄養補助食品成分市場ヘルスベネフィット

• 骨の健康
• 腸の健康
• 心臓の健康
• 免疫
• 栄養
• 体重管理

第9章 活性栄養補助食品成分市場：用途別

• 動物栄養
• 栄養補助食品
• 機能性飲料
• 機能性食品

第10章 活性栄養補助食品成分市場：流通チャネル別

• オフライン
• オンライン

第11章 南北アメリカの活性栄養補助食品成分市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の活性栄養補助食品成分市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの活性栄養補助食品成分市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ラクトフェリン生産におけるイノベーション：Triplebar BioとFrieslandCampina Ingredientsのコラボレーション
  • ニュートリリード、先駆的なベニカロスプレバイオティクスファイバー事業拡大のため450万ユーロ（496万米ドル）を確保
  • 認知機能の向上：バルケムのビタコリン生産の戦略的拡大
  • 強化された流通契約により、カナダにおける主要な栄養補助食品原料へのアクセスが向上
  • ロケット社、バルセロナのCPhIで栄養補助食品向けの革新的な水分保護賦形剤を発表
  • OmyaがCPhI Barcelonaで新しい栄養補助食品添加剤を発表
  • バレンツ・インターナショナル、ビオグレディアの戦略的買収により栄養補助食品事業を拡大
  • デイリーゴールド、ヴィタ・アクティブスの戦略的買収で将来の成長を確保
  • エボニックとサフィック・アルキャンの戦略的提携により、欧州、トルコ、エジプトでの栄養補助食品の流通が強化される
  • 戦略的拡大：FytexiaがVital Solutionsを買収し、健康成分ポートフォリオを強化
  • エンゼン・バイオサイエンス、世界のプレゼンスを高めるために多額の資金を確保

企業一覧

• Koninklijke DSM N.V.
• Fonterra Co-operative Group Limited
• The Lubrizol Corporation
• ChromaDex Corporation
• Corbion NV
• Balchem Corporation
• Divi's Laboratories Limited
• Barrington Chemical Corporation
• Tate & Lyle PLC
• Arla Foods amba
• Associated British Foods PLC
• BASF SE
• Kyowa Kirin Co., Ltd.
• Lonza Group AG
• Indena S.p.A.
• Kerry Group PLC
• DuPont de Nemours, Inc.
• Cargill, Incorporated
• Glanbia PLC
• BI Nutraceuticals, Inc. by MB Holding GmbH & Co. KG
• Novozymes A/S by Novonesis Group
• Archer-Daniels-Midland Company
• Biovedic Nutraceutical
• Evonik Industries AG
• Ajinomoto Co., Inc.

LIST OF FIGURES

• FIGURE 1. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET RESEARCH PROCESS
• FIGURE 2. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET DYNAMICS
• TABLE 7. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY CAROTENOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FIBERS & SPECIALTY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY MINERALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY PHYTOCHEMICAL & PLANT EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY PROTEINS & AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY BONE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY GUT HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEART HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY IMMUNITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FUNCTIONAL FOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 51. CANADA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 52. CANADA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. CHINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 78. CHINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 79. CHINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. CHINA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. INDIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 83. INDIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 84. INDIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. INDIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. ITALY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. ITALY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 169. ITALY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 170. ITALY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. ITALY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 187. POLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. POLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 189. POLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 190. POLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. POLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 192. QATAR ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. QATAR ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 194. QATAR ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 195. QATAR ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. QATAR ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY HEALTH BENEFIT, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 243. ACTIVE NUTRACEUTICALS INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Active Nutraceuticals Ingredients Market was valued at USD 227.34 billion in 2023, expected to reach USD 245.41 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 392.58 billion by 2030.

The active nutraceuticals ingredients market encompasses bioactive compounds that provide health benefits beyond basic nutrition when consumed. These ingredients include vitamins, minerals, probiotics, antioxidants, amino acids, and plant extracts, often used in functional foods, dietary supplements, and beverages. Their necessity stems from the growing consumer inclination towards preventive healthcare and wellness, driven by rising awareness of chronic diseases linked to lifestyle choices. Key applications focus on immune support, cognitive health, anti-aging, digestive wellness, and stress management, while end-users primarily comprise the food and beverage, pharmaceutical, and cosmetics industries. Market growth is significantly influenced by the aging global population, increasing healthcare costs, and consumer demand for natural and organic products. Additionally, the regulatory landscape, emphasizing sustainability and safety standards, presents opportunities for market expansion through innovation in product formulations and sourcing sustainable ingredients.

Opportunities lie in developing personalized nutrition solutions, utilizing artificial intelligence and big data analytics to cater to individual dietary needs and health conditions. The expansion into emerging markets, where awareness and disposable income are rising, further presents avenues for growth. However, challenges such as stringent regulatory requirements, high R&D and production costs, and the complexity of ingredient bioavailability and stability pose limitations. Counterfeit and low-quality products in the market further complicate consumer trust. Innovation should focus on enhancing bioavailability through advanced delivery systems like nanotechnology and encapsulation. Research into alternative, plant-based protein sources and understanding the gut microbiome's impact on health remains crucial. The market exhibits a dynamic, innovation-driven nature with a need for continuous adaptation to consumer trends and regulatory changes. Companies should leverage partnerships with academic institutions for cutting-edge research, prioritize transparency in sourcing and production, and engage in consumer education to highlight the benefits of nutraceuticals. As the line between food and medicine blurs, businesses must focus on targeted product development, addressing specific health issues to maintain competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Active Nutraceuticals Ingredients Market

The Active Nutraceuticals Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing awareness related to health and well-being
  • Ongoing innovations in extraction and processing technologies
• Market Restraints
  • Product development complexities along with adulteration issues in active nutraceutical ingredients
• Market Opportunities
  • Development of novel products using active nutraceutical ingredients
  • Surging preference for plant-based nutraceutical ingredients
• Market Challenges
  • Time-consuming clinical trials to substantiate health claims and strict government approval procedures

Porter's Five Forces: A Strategic Tool for Navigating the Active Nutraceuticals Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Active Nutraceuticals Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Active Nutraceuticals Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Active Nutraceuticals Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Active Nutraceuticals Ingredients Market

A detailed market share analysis in the Active Nutraceuticals Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Active Nutraceuticals Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Active Nutraceuticals Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Active Nutraceuticals Ingredients Market, highlighting leading vendors and their innovative profiles. These include Koninklijke DSM N.V., Fonterra Co-operative Group Limited, The Lubrizol Corporation, ChromaDex Corporation, Corbion NV, Balchem Corporation, Divi's Laboratories Limited, Barrington Chemical Corporation, Tate & Lyle PLC, Arla Foods amba, Associated British Foods PLC, BASF SE, Kyowa Kirin Co., Ltd., Lonza Group AG, Indena S.p.A., Kerry Group PLC, DuPont de Nemours, Inc., Cargill, Incorporated, Glanbia PLC, BI Nutraceuticals, Inc. by MB Holding GmbH & Co. KG, Novozymes A/S by Novonesis Group, Archer-Daniels-Midland Company, Biovedic Nutraceutical, Evonik Industries AG, and Ajinomoto Co., Inc..

Market Segmentation & Coverage

This research report categorizes the Active Nutraceuticals Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Carotenoids, Fibers & Specialty Carbohydrates, Minerals, Omega-3 Fatty Acids, Phytochemical & Plant Extracts, Proteins & Amino Acids, and Vitamins.
• Based on Form, market is studied across Dry and Liquid.
• Based on Health Benefit, market is studied across Bone Health, Gut Health, Heart Health, Immunity, Nutrition, and Weight Management.
• Based on Application, market is studied across Animal Nutrition, Dietary Supplements, Functional Beverages, and Functional Food.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing awareness related to health and well-being
    • 5.1.1.2. Ongoing innovations in extraction and processing technologies
  • 5.1.2. Restraints
    • 5.1.2.1. Product development complexities along with adulteration issues in active nutraceutical ingredients
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of novel products using active nutraceutical ingredients
    • 5.1.3.2. Surging preference for plant-based nutraceutical ingredients
  • 5.1.4. Challenges
    • 5.1.4.1. Time-consuming clinical trials to substantiate health claims and strict government approval procedures
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Advancements in nutraceuticals in the form of antioxidant-rich carotenoids to probiotics
  • 5.2.2. Form: Enhanced use of dry form ingredients owing to its stability and shelf-life
  • 5.2.3. Health Benefit: Exponential use of active nutraceutical ingredients for building nutrition and immunity
  • 5.2.4. Application: Diverse applications of nutraceuticals in animal nutrition, dietary supplements, and personal care
  • 5.2.5. Distribution Channel: Wide availability of active nutraceutical ingredients through online distribution channels
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Active Nutraceuticals Ingredients Market, by Type

• 6.1. Introduction
• 6.2. Carotenoids
• 6.3. Fibers & Specialty Carbohydrates
• 6.4. Minerals
• 6.5. Omega-3 Fatty Acids
• 6.6. Phytochemical & Plant Extracts
• 6.7. Proteins & Amino Acids
• 6.8. Vitamins

7. Active Nutraceuticals Ingredients Market, by Form

• 7.1. Introduction
• 7.2. Dry
• 7.3. Liquid

8. Active Nutraceuticals Ingredients Market, by Health Benefit

• 8.1. Introduction
• 8.2. Bone Health
• 8.3. Gut Health
• 8.4. Heart Health
• 8.5. Immunity
• 8.6. Nutrition
• 8.7. Weight Management

9. Active Nutraceuticals Ingredients Market, by Application

• 9.1. Introduction
• 9.2. Animal Nutrition
• 9.3. Dietary Supplements
• 9.4. Functional Beverages
• 9.5. Functional Food

10. Active Nutraceuticals Ingredients Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
• 10.3. Online

11. Americas Active Nutraceuticals Ingredients Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Active Nutraceuticals Ingredients Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Active Nutraceuticals Ingredients Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Innovation in Lactoferrin Production: A Collaboration between Triplebar Bio and FrieslandCampina Ingredients
  • 14.3.2. NutriLeads Secures Euro 4.5 Million(USD 4.96 million) for Pioneering BeniCaros Prebiotic Fiber Expansion
  • 14.3.3. Enhancing Cognitive Health: Balchem's Strategic Expansion of VitaCholine Production
  • 14.3.4. Enhanced Distribution Agreement Elevates Access to Leading Nutraceutical Ingredients in Canada
  • 14.3.5. Roquette Unveils Innovative Moisture-Protective Excipients for Nutraceuticals at CPhI Barcelona
  • 14.3.6. Omya Releases Novel Nutraceutical Excipients at CPhI Barcelona
  • 14.3.7. Barentz International Expands Nutraceutical Presence with Strategic Acquisition of Biogredia
  • 14.3.8. Dairygold Secures Future Growth with Strategic Acquisition of Vita Actives
  • 14.3.9. Strategic Partnership Between Evonik and Safic-Alcan Enhances Nutraceutical Distribution in Europe, Turkey, and Egypt
  • 14.3.10. Strategic Expansion: Fytexia Acquires Vital Solutions to Bolster Health Ingredient Portfolio
  • 14.3.11. Enzene Biosciences Secures Substantial Funding to Elevate Global Presence

Companies Mentioned

• 1. Koninklijke DSM N.V.
• 2. Fonterra Co-operative Group Limited
• 3. The Lubrizol Corporation
• 4. ChromaDex Corporation
• 5. Corbion NV
• 6. Balchem Corporation
• 7. Divi's Laboratories Limited
• 8. Barrington Chemical Corporation
• 9. Tate & Lyle PLC
• 10. Arla Foods amba
• 11. Associated British Foods PLC
• 12. BASF SE
• 13. Kyowa Kirin Co., Ltd.
• 14. Lonza Group AG
• 15. Indena S.p.A.
• 16. Kerry Group PLC
• 17. DuPont de Nemours, Inc.
• 18. Cargill, Incorporated
• 19. Glanbia PLC
• 20. BI Nutraceuticals, Inc. by MB Holding GmbH & Co. KG
• 21. Novozymes A/S by Novonesis Group
• 22. Archer-Daniels-Midland Company
• 23. Biovedic Nutraceutical
• 24. Evonik Industries AG
• 25. Ajinomoto Co., Inc.